William S. Reardon

William S. Reardon is a declared insider at 7 companies; the most frequent names are Madrigal Pharmaceuticals, Inc., Idera Pharmaceuticals, Inc. and abrdn Life Sciences Investors. The record holds 34 filings, for trades running from 8 June 2006 to 6 April 2021.

The open-market record is one-sided, with 12 purchases worth €124k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 22 share grants. So far in 2021, the count stands at 2 purchases and no sales.

In size, the median ticket on the buying side is €5,301. Ninety days after publication, 6 purchases show a median change of +7.7%, with the price up in 100% of them. They describe history only and say nothing certain about the share price ahead.

The latest filing, published on 8 April 2021, reports a share grant of €5,836 in abrdn World Healthcare Fund. The last purchase on record was published on 1 March 2021, which is 2,063 days ago. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.